162 related articles for article (PubMed ID: 35467735)
1. Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US.
Dedhia PH; Saucke MC; Long KL; Doherty GM; Pitt SC
JAMA Netw Open; 2022 Apr; 5(4):e228722. PubMed ID: 35467735
[TBL] [Abstract][Full Text] [Related]
2. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
Jensen CB; Saucke MC; Francis DO; Voils CI; Pitt SC
Thyroid; 2020 May; 30(5):696-703. PubMed ID: 31910092
[No Abstract] [Full Text] [Related]
3. Terminology Change for Small Low-Risk Papillary Thyroid Cancer As a Response to Overtreatment: Results from Three Australian Community Juries.
Shih P; Nickel B; Degeling C; Thomas R; Brito JP; McLeod DSA; McCaffery K; Carter SM
Thyroid; 2021 Jul; 31(7):1067-1075. PubMed ID: 33238815
[No Abstract] [Full Text] [Related]
4. Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.
Krajewska J; Kukulska A; Oczko-Wojciechowska M; Kotecka-Blicharz A; Drosik-Rutowicz K; Haras-Gil M; Jarzab B; Handkiewicz-Junak D
Front Endocrinol (Lausanne); 2020; 11():571421. PubMed ID: 33123090
[TBL] [Abstract][Full Text] [Related]
5. Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
Kaliszewski K; Diakowska D; Wojtczak B; Rudnicki J
PLoS One; 2020; 15(7):e0236257. PubMed ID: 32692768
[TBL] [Abstract][Full Text] [Related]
6. Progress and Challenges in Thyroid Cancer Management.
Haymart MR
Endocr Pract; 2021 Dec; 27(12):1260-1263. PubMed ID: 34562612
[TBL] [Abstract][Full Text] [Related]
7. Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.
Cartwright S; Fingeret A
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):351-357. PubMed ID: 32701516
[TBL] [Abstract][Full Text] [Related]
8. Slow Growth, Excellent Prognosis: The Treatment and Overtreatment of Papillary Thyroid Cancer.
Georgiades C
Radiology; 2024 Apr; 311(1):e240207. PubMed ID: 38563672
[No Abstract] [Full Text] [Related]
9. Overdiagnosis of thyroid cancer in the Marne and Ardennes Departments of France from 1975 to 2014.
Saint-Martin C; Dramé M; Dabakuyo S; Kanagaratnam L; Arveux P; Schvartz C
Ann Endocrinol (Paris); 2017 Feb; 78(1):27-32. PubMed ID: 27641079
[TBL] [Abstract][Full Text] [Related]
10. [Controversy and boundary in the diagnose and treatment of thyroid cancer].
Hu QY; Yang LC; Huang T
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1566-1571. PubMed ID: 38742342
[TBL] [Abstract][Full Text] [Related]
11. Papillary lesions of indolent course: reducing the overdiagnosis of indolent papillary thyroid cancer and unnecessary treatment.
Brito JP; Davies L; Zeballos-Palacios C; Morris JC; Montori VM
Future Oncol; 2014 Jan; 10(1):1-4. PubMed ID: 24328403
[No Abstract] [Full Text] [Related]
12. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
Jung M
Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.
Nickel B; Barratt A; McGeechan K; Brito JP; Moynihan R; Howard K; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):867-874. PubMed ID: 30335875
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis of Thyroid Cancer: Is This Not an Ethical Issue for Pathologists As Well As Radiologists and Clinicians?
Schnadig VJ
Arch Pathol Lab Med; 2018 Sep; 142(9):1018-1020. PubMed ID: 30141995
[No Abstract] [Full Text] [Related]
15. Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors.
Matsuzu K; Sugino K; Masudo K; Mori K; Ono R; Yamazaki H; Masaki C; Akaishi J; Kiyomi Yamada H; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2020 Aug; 67(8):869-876. PubMed ID: 32350192
[TBL] [Abstract][Full Text] [Related]
16. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology.
Bychkov A; Jung CK; Liu Z; Kakudo K
Endocr Pathol; 2018 Sep; 29(3):276-288. PubMed ID: 29476382
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
O'Grady TJ; Gates MA; Boscoe FP
Int J Cancer; 2015 Dec; 137(11):2664-73. PubMed ID: 26069163
[TBL] [Abstract][Full Text] [Related]
19. The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
Lubitz CC; Sosa JA
Cancer; 2016 Dec; 122(24):3754-3759. PubMed ID: 27517675
[TBL] [Abstract][Full Text] [Related]
20. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
